Covered recipient · General Payments record
HANNAH REBEKAH PRONTIKER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,650.84
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $189.91 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $72.40 | 4 |
| Lilly USA, LLC | $55.16 | 3 |
| Acerta Pharma LLC | $18.40 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.70 | 1 |
| PFIZER INC. | $14.66 | 1 |
| ABBVIE INC. | $13.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.59 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108043252 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.40 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104512378 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.70 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117937883 | CMS |
| Lilly USA, LLC | $20.39 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135679031 | CMS |
| Lilly USA, LLC | $18.39 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135663745 | CMS |
| Lilly USA, LLC | $16.38 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135663747 | CMS |
| Novo Nordisk Inc | $19.37 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100489261 | CMS |
| Novo Nordisk Inc | $18.65 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100508341 | CMS |
| Novo Nordisk Inc | $16.95 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100237456 | CMS |
| Novo Nordisk Inc | $17.43 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100454450 | CMS |
| PFIZER INC. | $14.66 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131257542 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.